XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
0.3791
+0.0341 (9.88%)
At close: Oct 2, 2026, 4:00 PM EDT
1.650
+1.271 (335.24%)
After-hours: Oct 2, 2026, 7:00 PM EDT
XORTX Therapeutics Employees
As of December 31, 2023, XORTX Therapeutics had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,246,379
Market Cap
3.11M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2023 | 3 | 0 | - | 2 | 1 |
| Dec 31, 2022 | 3 | 0 | - | 3 | 0 |
| Jan 1, 2022 | 3 | - | - | 3 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 35 |
| Aptevo Therapeutics | 33 |
| GeoVax Labs | 19 |
| VivoSim Labs | 15 |
| Revelation Biosciences | 9 |
| Cadrenal Therapeutics | 5 |
| Jupiter Neurosciences | 5 |
| Addex Therapeutics | 3 |
XRTX News
- 16 days ago - Xortx Therapeutics announces planned FDA IND submission for XRx-026 - TheFly
- 16 days ago - XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity - GlobeNewsWire
- 24 days ago - Xortx Therapeutics initiates clinical, commercial manufacturing of Xorlo - TheFly
- 24 days ago - XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™ - GlobeNewsWire
- 26 days ago - XORTX Re-Engages Investor Relations Program - GlobeNewsWire
- 5 weeks ago - Xortx Therapeutics terminates investor relations, marketing agreement - TheFly
- 5 weeks ago - XORTX Announces Termination and Postponement of Investor Relations Program - GlobeNewsWire
- 2 months ago - XORTX Announces Director Resignation - GlobeNewsWire